Product image of Migtan (Sumatriptan) supplied by GNH India

Migtan

Active Ingredient:
Sumatriptan
Origin:
EU

Migtan (Sumatriptan)

Sumatriptan, the active ingredient in Migtan, is a Triptan (5‑HT1B/1D receptor agonist) presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks, with or without aura, in adult patients.

GNH India supplies Migtan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides batch‑tested products with full documentation for regulatory review. Migtan is distributed through a secure supply chain ensuring product integrity from manufacturing to end‑user.

Manufacturer / TM Owner

Bausch Health Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Sumatriptan is a triptan medication used to treat migraine by targeting serotonergic pathways.

  • Migraine attack: rapid relief of headache pain, nausea, photophobia and phonophobia.
  • Migraine with aura: alleviates headache phase following visual or sensory aura.
  • Migraine without aura: reduces severity and duration of headache when taken early in the attack.

How It Works

  • Sumatriptan selectively binds to serotonin 5‑HT1B and 5‑HT1D receptors on intracranial blood vessels and trigeminal nerve terminals. Activation of these receptors causes cranial vasoconstriction and inhibits the release of pro‑inflammatory neuropeptides, thereby interrupting the pain signaling cascade responsible for migraine attacks.

Side Effects

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Dizziness: transient feeling of light‑headedness.
  • Tingling or paresthesia: often in the face or extremities.
  • Chest discomfort: sensation of pressure or tightness.
  • Fatigue: general feeling of tiredness.
  • Dry mouth: reduced salivation.

Serious or Rare Side Effects

  • Coronary vasospasm: chest pain due to reduced coronary blood flow.
  • Severe hypertension: sudden increase in blood pressure.
  • Serotonin syndrome: agitation, hyperthermia, muscle rigidity when combined with serotonergic agents.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Cardiac arrhythmia: irregular heart rhythm.
  • Myocardial infarction: rare heart attack in susceptible individuals.

Precautions & Warnings

Before prescribing Sumatriptan, clinicians should evaluate the following:

  • Cardiovascular assessment: avoid use in patients with uncontrolled hypertension or known coronary artery disease.
  • Hemiplegic migraine: contraindicated due to risk of cerebrovascular events.
  • Concomitant ergotamine: avoid co‑administration to reduce vasospasm risk.
  • Serotonergic drugs: monitor for signs of serotonin syndrome when used with SSRIs, SNRIs or MAO inhibitors.
  • Pregnancy and lactation: use only if potential benefit justifies potential risk; data are limited.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Sumatriptan may interact with several drug classes. Awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid)

  • MAO inhibitors: increased risk of serotonin syndrome.
  • Other triptans: additive vasoconstrictive effects.
  • Ergot alkaloids: heightened vasospasm potential.
  • SSRIs/SNRIs: potential for serotonin syndrome.
  • Serotonin‑releasing agents: increased serotonergic toxicity.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: may enhance blood pressure lowering.
  • CYP3A4 inhibitors (e.g., ketoconazole): may raise sumatriptan plasma levels.
  • Oral contraceptives: slight increase in migraine frequency.
  • Antihistamines: may augment dizziness.
  • Certain antibiotics (e.g., erythromycin): modest effect on metabolism.

Frequently Asked Questions

Migtan contains sumatriptan, a triptan class medication indicated for the acute treatment of migraine attacks, with or without aura, in adult patients. It helps relieve headache pain and associated symptoms such as nausea, photophobia, and phonophobia when taken early in the migraine episode.

Sumatriptan acts as a selective agonist at serotonin 5‑HT1B and 5‑HT1D receptors located on intracranial blood vessels and trigeminal nerve endings. By stimulating these receptors, it causes constriction of dilated cranial vessels and blocks the release of neuropeptides that transmit pain, thereby interrupting the migraine cascade.

The specific dose and dosing schedule of Migtan are determined by the prescribing healthcare professional based on the individual patient's needs, severity of migraine, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for sumatriptan in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To request Migtan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Migtan (sumatriptan) belongs to the triptan class, which is generally more effective for moderate to severe migraine attacks than simple analgesics such as NSAIDs. Compared with newer CGRP antagonists, triptans act via vasoconstriction and have a longer history of use, but they may be contraindicated in patients with certain cardiovascular conditions.

Migtan tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, heat, and direct sunlight to maintain stability and potency throughout the shelf life.

Migtan is taken orally as a tablet. The tablet should be swallowed whole with water, preferably as soon as migraine symptoms begin. Patients should not crush, chew, or dissolve the tablet unless specifically instructed by a healthcare professional.

Serious risks include coronary vasospasm, severe hypertension, myocardial infarction, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience chest pain, severe headache, or any signs of an allergic reaction.

Migtan is contraindicated in patients with uncontrolled hypertension, known coronary artery disease, history of myocardial infarction, severe hepatic impairment, hemiplegic or basilar migraine, and those who are currently taking ergotamine-containing medications or other triptans.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sumatriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT